Dearsir,

I
amDrZhi-QingChen,fromtheDepartmentof OphthalmologyoftheSecondAffiliatedHospitalof ZhejiangUniversityinHangzhou,ZhejiangProvince,China. Iwritetopresenttwocasesofneovascularage-related maculardegeneration(AMD)occurredretinalpigment epithelium(RPE)tearsafterdifferenttreatment. RPEtearisararecomplicationofneovascularAMD, especiallyinassociationwithalargepigmentepithelial detachment (PED) [1] [2] [3] .RPEtearsmaybespontaneous associatedwithneovascularAMD [4] .Recentevidence indicatesthattherateofthiscomplicationmaybeincreased afteranti-vascularendothelialgrowthfactor(anti-VEGF) therapy [5] [6] [7] . WepresenttwocasesofneovascularAMDoccurredRPE tears,oneafterreceivingintravitrealanti-VEGFtherapyand theotheroneafterphotodynamictreatment(PDT [8] introducedanewgradingsystemforRPEtears.They classifyRPEtearsbasedonthelongestlineardiameterinthe vectordirectionofthetearanddefined4gradetears.Higher gradetearswerelargerwithaworseprognosis.TheRPE tearinthefirstpatientlocatedinthesubfoveathoughitwas smallerthan200 滋m.Thetearinthesecondonewas evaluatedasgrade4.Sotheybothhadpoorvisualacuity. ThereportedincidenceofRPEtearsintheliteraturespansa broadrange,from1.8%to27%,inbothnaturalhistoryand interventionalseries [9] .Recentseveralreports [5] [6] [7] indicates thattherateofthiscomplicationmaybeincreased,or alternativelyaccelerated,afteranti-VEGFtherapy.However, asstudiedinanti-VEGFantibodyforthetreatmentof predominantlyclassic choroidalneovascularizationin age-relatedmaculardegeneration(ANCHOR),minimally classic/occulttrialoftheanti-VEGFantibodyranibizumabin thetreatmentofneovascularage-relatedmacular degeneration(MARINA),andaphaseIIIb,multicenter, randomized,double-masked,shaminjection-controlledstudy oftheefficacyandsafetyofranibizumab(PIER)trials,no statisticallysignificantdifferencesintheincidenceofRPE tearswithina2-yeartreatmentperiodwereobservedin patientswhoreceivedranibizumab(0.5or0.3mg)versus controltreatment,althoughmostRPEtearswithranibizumab injectionoccurredwithin3moofinitiatingtreatment [10] . Variousmechanismshavebeenproposedforthe developmentofRPEtears.Gass [11] andKrishan [12] proposedthatleakagefromsub-RPECNVcouldincrease hydrostaticpressuresufficienttoteartheRPE.Bird [13] implicatedthe RPE pumpingmechanism asamajor contributortofluidaccumulationwithinaPEDandtothe developmentofanRPEtearsecondarytohydrostaticforces. Inadditiontohydrostaticstresses,dynamicunderlyingCNV membranesmaycontractandexertsignificanttangential forcesontheposteriorsurfaceofthedetachedRPE [14] . Thermal contractionofCNVinthesettingoflaser photocoagulationwaslaterproposedasanothermechanism oftearing [15] .PDTalonehasbeenshowntobeharmfulasit increasestheriskofRPEtear,hemorrhageandsudden visualacuitydecrease [16] [17] .Theincreaseinthemagnitudeof theseforcesafterVEGFtherapycontributestothestructural failureoftheRPEmonolayer [18] . IncreasingPEDheightstronglypredictedtheriskofRPE tearingandeyeswithoutPEDcarrieda0.3%risk,100 滋m PEDscarrieda0.5%risk,and600 滋mPEDscarrieda 14.8%riskoftearingfollowingintravitrealbevacizumab [2] .It isnotonlytheheightofthePED,butalsotheratiobetween theheight/widthofPEDisariskfactor [19] .Inadditiontoa largePEDsizeservesasapredictorforRPEtears,Chan [3] reportedastrongertendencytoteardevelopmentin thosePEDlesionsthatshowasmallerratioofCNVsizeto PEDsize,especiallysmallerinfibrovascularPEDlesions.In ourtwocases,weanalyzedtheriskfactoroffirstcaseis occultCNVwithfibrovascularPED.Thesecondoneislarge andhighPED.TheheightofPEDwasbothhigherthan 400 滋mintwocases. Retreatmentdecisionsarecomplex,giventhatfluidleakage mayoccurnotonlyduetoCNVactivity,butalsosecondary totheabsenceofRPE,whichfunctionstopumpoutfluid fromthesubretinalspace.Ajudgmentcanbemadewhether theleakageislikelyfromCNVactivitybycomparingthe locationandtheextentofthepre-tearCNVleakagewiththe post-tearangiogram.Severalreportshavesuggestedthat persistentanti-VEGFtherapyisimportantineyeswithRPE tearsforcontinuedsuppressionofneovascularactivity. Anti-VEGFtherapyappearssafeineyeswithRPEtear secondarytoAMDandmayhelptostabilizeoreven improveacuityinsomecases [10, 20] .
